Pacira BioSciences, Inc.
PCRX· Nasdaq
Released Aug 6, 2020, after the close
10-Q filed Aug 6, 2020, 37 days after period end · 0001396814-20-000029
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Revenue | $75.51M | $101.82M | $80.72M | $70.14M |
| Net Income | -$7.27M | $2.73M | $2.56M | -$19.74M |
| EPS Diluted | -$0.17 |
Pacira BioSciences, Inc. · CIK 1396814 · Engraved from SEC EDGAR
| $0.06 |
| $0.06 |
| -$0.49 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.